BFA
IDXG

BlackRock Fund Advisors’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History

BlackRock Fund Advisors’s Portfolio IDXG Stock Details IDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1K Buy
27
+5
+23% +$159 ﹤0.01% 4222
2016
Q3 		$0 Buy
22
+2
+10% +$55 ﹤0.01% 4279
2016
Q2 		$1K Buy
+20
New +$753 ﹤0.01% 4308
2015
Q2 		– Sell
-318
Closed -$43K – 3915
2015
Q1 		$43K Sell
318
-22
-6% -$3.6K ﹤0.01% 3709
2014
Q4 		$61K Buy
340
+24
+8% +$4.27K ﹤0.01% 3660
2014
Q3 		$76K Sell
316
-23
-7% -$7.68K ﹤0.01% 3672
2014
Q2 		$148K Buy
339
+10
+3% +$4.61K ﹤0.01% 3568
2014
Q1 		$151K Buy
329
+40
+14% +$20.8K ﹤0.01% 3526
2013
Q4 		$139K Buy
289
+12
+4% +$5.87K ﹤0.01% 3523
2013
Q3 		$133K Buy
277
+22
+9% +$10.5K ﹤0.01% 3503
2013
Q2 		$120K Buy
+255
New +$116K ﹤0.01% 3484

Other funds holding IDXG

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $2.24B AUM 17.11% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.69B AUM 19.05% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return